Nipro Corporation competitors and similar companiesClear all
Nipro Corporation's competitors and similar companies include West Pharmaceutical Services, Kuraray, Takeda Pharmaceutical, Astellas Pharma and Nikkiso.
 Nipro Corporation Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging. |  West Pharmaceutical Services West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally. |  Kuraray Kuraray is a company that manufactures chemicals, synthetic and chemical fibers, and other materials. |  Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Nikkiso Nikkiso (日機装株式会社) is a company that engages in industrial, precision equipment, aerospace, and medical businesses. | ||
Founding Date | Founding Date 1954 | Founding Date 1923 | Founding Date 1926 | Founding Date 1781 | Founding Date 1923 | Founding Date 1953 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Osaka, JP HQ Bunkyo City, JP Kusatsu, JP Kusatsu, JP Ohdate, JP | Locations Exton, US HQ Munro, AR Macquarie Park, AU São Paulo, BR Shanghai, CN Shanghai, CN Tibito, CO see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | |||
Employees | Employees 36,259 | Employees 10,0659% increase | Employees 11,3301% increase | Employees 47,3471% increase | Employees 15,4553% decrease | Employees 8,7621% increase |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) 25 b | Valuation ($) 3 b | Valuation ($) 51.9 b | Valuation ($) 26.6 b | Valuation ($) 464.8 m |
Twitter followers | Twitter followers N/A | Twitter followers 2.6 k | Twitter followers 908 | Twitter followers N/A | Twitter followers 50.4 k | Twitter followers 30 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 42 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 25 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 5.8 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 54.76% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 96% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 3.5 | Employee Rating 3.7 | Employee Rating N/A | Employee Rating 4 | Employee Rating 4.2 | Employee Rating N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) ¥442.5b (FY, 2020) | Revenue (est.) $2.9b (FY, 2022) | Revenue (est.) ¥756.4b (FY, 2022) | Revenue (est.) ¥3.6t (FY, 2022) | Revenue (est.) ¥1.3t (FY, 2022) | Revenue (est.) ¥177.1b (FY, 2022) |
Cost of goods | Cost of goods ¥308.3b (FY, 2020) | Cost of goods $1.8b (FY, 2022) | Cost of goods ¥449.3b (FY, 2022) | Cost of goods ¥523.7b (FY, 2022) | Cost of goods ¥173.3b (FY, 2022) | Cost of goods ¥121.6b (FY, 2022) |
Gross profit | Gross profit ¥134.2b (FY, 2020) | Gross profit $1.1b (FY, 2022) | Gross profit ¥307.1b (FY, 2022) | Gross profit ¥3.1t (FY, 2022) | Gross profit ¥1.2t (FY, 2022) | Gross profit ¥93.7b (FY, 2022) |
Net income | Net income (¥11.6b) (FY, 2020) | Net income $585.9m (FY, 2022) | Net income ¥55.6b (FY, 2022) | Net income ¥230.2b (FY, 2022) | Net income ¥124.1b (FY, 2022) | Net income ¥13.8b (FY, 2022) |
Operating ⚠ | ||||||
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 1 (Jul, 2019) | Phase I Trials Products (Oncology) 1 (FY, 2020) | Phase I Trials Products (Oncology) N/A |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 8 (Oct, 2019) | Phase II Trials Products (Oncology) 1 (FY, 2020) | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 8 (May, 2021) | Phase III Trials Products (Oncology) 4 (Oct, 2020) | Phase III Trials Products (Oncology) N/A |
For sources of this data, please see the company profile
View company profiles
West Pharmaceutical Services
HQ
Exton, US
Employees
10,065↑ 9% increase
West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally.
View companyKuraray
HQ
Chiyoda City, JP
Employees
11,330↑ 1% increase
Kuraray is a company that manufactures chemicals, synthetic and chemical fibers, and other materials.
View company
Takeda Pharmaceutical
HQ
Tokyo, JP
Employees
47,347↑ 1% increase
Takeda Pharmaceutical is a biopharmaceutical company.
View companyAstellas Pharma
HQ
Tokyo, JP
Employees
15,455↓ 3% decrease
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company